Department of Cardiac Sciences, Libin Cardiovascular Institute, University of Calgary, GAC70 HRIC Bldg, 3280 Hospital Dr. NW, Calgary, AB, T2N 4Z6, Canada.
Division of Clinical Pharmacology, Department of Medicine, Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Clin Auton Res. 2021 Jun;31(3):365-368. doi: 10.1007/s10286-021-00798-2. Epub 2021 Mar 19.
COVID-19 is a global pandemic that has had a devastating effect on the health and economy of much of human civilization. While the acute impacts of COVID-19 were the initial focus of concern, it is becoming clear that in the wake of COVID-19, many patients are developing chronic symptoms that have been called Long-COVID. Some of the symptoms and signs include those of postural tachycardia syndrome (POTS). Understanding and managing long-COVID POTS will require a significant infusion of health care resources and a significant additional research investment. In this document from the American Autonomic Society, we outline the scope of the problem, and the resources and research needed to properly address the impact of Long-COVID POTS.
COVID-19 是一场全球性大流行病，对人类文明的大部分地区的健康和经济造成了毁灭性的影响。虽然 COVID-19 的急性影响是最初关注的焦点，但很明显，在 COVID-19 之后，许多患者出现了被称为长新冠的慢性症状。其中一些症状和体征包括体位性心动过速综合征（POTS）。了解和管理长新冠 POTS 将需要大量的医疗保健资源和大量的额外研究投资。在美国自主神经学会的这份文件中，我们概述了这一问题的范围，以及为妥善解决长新冠 POTS 的影响所需的资源和研究。
